Author

Michael Dill

Institutions: Association of American Medical Colleges, German Cancer Research Center, Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases

Observed institutions: Association of American Medical Colleges, German Cancer Research Center, Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases

ORCID: 0009-0007-8169-7602

Observed ORCID: 0009-0007-8169-7602

OpenAlex ID: A5134060292

Real-World Outcomes of Ivosidenib in IDH1-Mutant Biliary Tract Cancer: A Multicenter Retrospective Analysis and Comparison with the TrinetX Database

2026 · Lena Dreikhausen, Alexander Olkus, et al. · Targeted Oncology · 1

Comparing Physicians’ Perceptions of Access to Behavioral Health Resources in Rural and Urban Practices

2026 · C. Holly A. Andrilla, Natalia V. Oster, et al. · The Journal of Rural Health

Durvalumab and tremelimumab, with or without lenvatinib, combined with transarterial chemoembolisation in participants with embolisation-eligible hepatocellular carcinoma (EMERALD-3): a global, randomised, open-label, sponsor-blinded, phase 3 study

2026 · Masatoshi Kudo, Masatoshi Kudo, et al. · The Lancet Oncology

Examining the academic physician workforce in the United States: work patterns, demographic characteristics, and COVID-19 effects

2026 · Luwam T Gebrekristos, Xiaochu Hu, et al. · Academic Medicine

27Novel blood metabolomic tests for the diagnosis of Primary Sclerosing Cholangitis and associated Cholangiocarcinoma

2026 · Ainhoa Lapitz, Elisa Catanzaro, et al. · The Oncologist

OS-007 Norucholic acid leads to biochemical and histologic improvement in primary sclerosing cholangitis: impact of concomitant ursodeoxycholic acid therapy

2026 · Michael Trauner, Palak J. Trivedi, et al. · Journal of Hepatology

SAT-257-YI Serum metabolomic signatures for cirrhosis detection and prediction in primary sclerosing cholangitis

2026 · Elisa Catanzaro, Ainhoa Lapitz, et al. · Journal of Hepatology

FRI-251 Favourable clinical outcomes with immunotherapy in patients with mismatch repair–deficient/microsatellite instability–high biliary tract cancers: investigation from a multicenter real-world cohort

2026 · Katharina Mitzlaff, Martha M Kirstein, et al. · Journal of Hepatology

168 - Novel Blood Metabolomic Tests for the Diagnosis of Primary Sclerosing Cholangitis and Associated Cholangiocarcinoma

2026 · Elisa Catanzaro, Ainhoa Lapitz, et al. · Gastroenterología y Hepatología

Works count: 9

Citation count: 1

H-index: 1

I10-index: